Cargando…
Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation
BACKGROUND: Direct oral anticoagulants (DOACs) are widely used for the prevention of stroke in nonvalvular atrial fibrillation (NVAF); however, real-world primary nonadherence (failing to collect the first prescription) has been measured in very few studies. OBJECTIVE: To report primary nonadherence...
Autores principales: | Charlton, Alethea, Vidal, Xavier, Sabaté, Mònica, Bailarín, Elena, Martínez, Lina María Leguízamo, Ibáñez, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391044/ https://www.ncbi.nlm.nih.gov/pubmed/34464214 http://dx.doi.org/10.18553/jmcp.2021.27.9.1210 |
Ejemplares similares
-
Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014) -
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007) -
Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021) -
Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients
With Nonvalvular Atrial Fibrillation
por: Kyriakou, Elias, et al.
Publicado: (2018) -
Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
por: Perreault, Sylvie, et al.
Publicado: (2019)